Ollivier Legrand

No ORCID on file · 2 papers in corpus · active 1996-2023

Study types

  • article 2
article 2023
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
·doi:10.1016/s0140-6736(22)02036-0
article 1996
Treatment of agnogenic myeloid metaplasia with danazol: A report of four cases
·doi:10.1002/(sici)1096-8652(199612)53:4<239::aid-ajh5>3.0.co;2-z

Peripheral cytopenias are common in patients with agnogenic myeloid metaplasia (AMM). They are an important cause of morbidity and mortality, and their treatment is difficult. We report on 4 patients with AMM and severe cytopenia treated wi…